Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | CTMX CytomX Therapeutics, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $2.70 -1.8% | $14.86 -2.5% |
| StockIQ Score | 35F Weak Risk: High | 36F Weak Risk: Medium |
| Technical | 13F | 13F |
| Fundamental | 30F | 35F |
| Growth | 43D | 50C- |
| Fair Value | 38F | 38F |
| News | 62C+ | 50C- |
| Quality | 58C | 50C- |
| Risk | 40D | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
CTMX scores higher on the overall investorScore (49 vs 41) and technicalScore (63 vs 34), indicating stronger market momentum. AAPG leads in fundamentalScore (35 vs 30) and growthScore (50 vs 43), suggesting better fundamentals and growth prospects. Both have the same valuationScore of 38. CTMX’s rating is MODERATE while AAPG’s is WEAK.
